Posted in

Poly Medicure’s Strategic Move: Acquiring Italy’s Citieffe

•Posted inMedical Updates
Indian doctor reviewing specialisation pathways for career advancement in 2025, reflecting emerging medical fields and clinical upskilling options.

Poly Medicure, a prominent Indian medical consumables manufacturer, has significantly expanded its portfolio through a strategic orthopedic device acquisition. The company announced the complete acquisition of Italy-based Citieffe, a specialist in orthopedic devices, for an enterprise value of €31 million (approximately Rs 324 crore). This move provides Poly Medicure a crucial entry point into the global orthopedics market, particularly in the trauma and extremities segment.

Details of the Orthopedic Device Acquisition Deal

Poly Medicure has signed a definitive agreement to acquire 100 percent of the equity stake in Medistream SA, which encompasses Citieffe SRL and its subsidiaries in the US and Mexico. The acquisition involves an upfront payment of €23 million, with Poly Medicure also assuming net external debt of €8.1 million, bringing the total transaction value to €31 million.

About Citieffe: A Specialist in Orthopedic Trauma

Citieffe, the acquired Italian manufacturer, holds expertise in the orthopedic trauma and extremities segment. The company boasts 45 patented devices, which it distributes across more than 25 countries globally. Furthermore, Citieffe maintains direct sales operations in key markets such as the U.S., Italy, and Mexico. In the calendar year 2024, Citieffe reported revenues of €17.3 million (around Rs 180 crore) and an EBITDA of €3.1 million (approximately Rs 32 crore).

Strategic Rationale Behind This Acquisition

This orthopedic device acquisition aligns with Poly Medicure’s vision to become a comprehensive healthcare solutions provider. Himanshu Baid, MD of Poly Medicure Limited, emphasized the synergies derived from combining Citieffe’s innovation pipeline with Polymed’s manufacturing scale and extensive commercial reach. This strategic move will deepen Poly Medicure’s foothold in crucial markets like the U.S., Italy, and Mexico. Indeed, the acquisition offers a platform to expand into attractive orthopedics segments, focusing on the fast-growing extremities sub-segment, and allows Poly Medicure to build a global orthopedic business.

Moving forward, Poly Medicure plans to enter the joint replacement market in the medium term. They also intend to hire more sales representatives in the country to bolster market coverage. Citieffe operates in a growing orthopedic segment, presenting significant potential to scale up business, especially in the US where product pricing is typically higher compared to other regions.

This marks Poly Medicure’s second acquisition within the same month, following its purchase of Netherlands-based cardiology catheter developer PendraCare Group for Rs 190 crore.

Frequently Asked Questions

Q1: What is the total value of the Poly Medicure acquisition of Citieffe?

The total transaction value for Poly Medicure’s acquisition of Citieffe is €31 million, which is approximately Rs 324 crore. This includes an upfront payment of €23 million and the assumption of €8.1 million in net external debt.

Q2: What is Citieffe’s specialization in the medical device market?

Citieffe specializes in the orthopedic trauma and extremities segment, developing and manufacturing medical devices for internal and external fracture fixation and limb reconstruction. They hold 45 patents for their devices.

Q3: How does this acquisition benefit Poly Medicure?

This acquisition provides Poly Medicure with a strategic entry into the global orthopedics market, particularly the high-growth trauma and extremities segment. It also expands Poly Medicure’s direct sales presence in the U.S., Italy, and Mexico, facilitating future entry into the joint replacement market and leveraging Citieffe’s innovation with Poly Medicure’s manufacturing capabilities.

References

  1. Poly Med picks up Italy-based orthopedic device maker for Rs 324 crore – ETHealthworld
  2. Poly Medicure to acquire Italy-based Citieffe Group for Rs. 324 crore – Pharmabiz.com
  3. Poly Medicure acquires Italy’s Citieffe Group for Rs. 324 Cr – Indian Pharma Post
  4. Poly Medicure Acquires Italy’s Citieffe via Medistream in ₹324 Crore Deal
  5. Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr – BioSpectrum India
  6. Poly Medicure to fully acquire Citieffe Group at value of ₹324 cr – Business Standard
  7. Polymed acquires 100% stake in Italy-based device maker Citieffe – Business Standard
  8. Citieffe S.r.l. – Medical Products Supplies Companies
  9. Citieffe 2025 Company Profile: Valuation, Funding & Investors | PitchBook
  10. Medical devices for traumatology – Citieffe
  11. Citieffe – ARCHIMED
  12. POLYMED – NSE (Press Release)

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.